{"schema_version":"secwatch.filing_event.v1","accession":"0001534969-24-000054","form_type":"8-K","ticker":"SERA","cik":"0001534969","company_name":"SERA PROGNOSTICS, INC.","filed_at":"2024-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.536635+00:00","generated_at":"2026-06-04T11:33:29.272837+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Sera Prognostics reports Q4/FY2023 results; DSMB stops PRIME study early for efficacy","bullets":["DSMB recommended stopping PRIME enrollment after co-primary endpoints met significance at interim analysis; preparing manuscript.","Q4 2023 revenue $41K; full-year revenue $306K; net loss $7.9M (Q4) and $36.2M (FY), improved from prior year.","Operating expenses down to $8.9M (Q4) from $10.5M; SG&A reduced to $5.0M from $6.9M.","Cash and securities $79.9M as of Dec 31, 2023.","Progress on PreTRM sample collection enhancements; launching in certain geographies; building patient-facing products."],"urls":{"canonical":"https://secwatch.observer/filing/0001534969-24-000054","json":"https://secwatch.observer/filing/0001534969-24-000054.json","markdown":"https://secwatch.observer/filing/0001534969-24-000054.md","text":"https://secwatch.observer/filing/0001534969-24-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534969/000153496924000054/0001534969-24-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534969/000153496924000054/sera-20240320.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T11:33:29.272837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"72de3f88ab3ccd2e853ada4d11300cbe3a30aaf7","claim":"SERA PROGNOSTICS, INC. reported financial results for the fourth quarter and fiscal year ended December 31, 2023.","evidence_excerpt":"On March 20, 2024, Sera Prognostics, Inc. (the \"Company\") issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2023 and providing business highlights.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534969/000153496924000054/0001534969-24-000054-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and fiscal year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}